These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32872181)

  • 1. Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates.
    Barani M; Sabir F; Rahdar A; Arshad R; Kyzas GZ
    Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32872181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
    Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
    Front Chem; 2022; 10():830133. PubMed ID: 35494646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Nanoparticles Probes for Prostate Cancer Imaging and Therapy.
    Gao T; Bi A; Yang S; Liu Y; Kong X; Zeng W
    Adv Exp Med Biol; 2018; 1096():99-115. PubMed ID: 30324350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics.
    Lima AR; Pinto J; Amaro F; Bastos ML; Carvalho M; Guedes de Pinho P
    Metabolites; 2021 Mar; 11(3):. PubMed ID: 33808897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An electrochemical biosensor to simultaneously detect VEGF and PSA for early prostate cancer diagnosis based on graphene oxide/ssDNA/PLLA nanoparticles.
    Pan LH; Kuo SH; Lin TY; Lin CW; Fang PY; Yang HW
    Biosens Bioelectron; 2017 Mar; 89(Pt 1):598-605. PubMed ID: 26868935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer.
    Cani AK; Hu K; Liu CJ; Siddiqui J; Zheng Y; Han S; Nallandhighal S; Hovelson DH; Xiao L; Pham T; Eyrich NW; Zheng H; Vince R; Tosoian JJ; Palapattu GS; Morgan TM; Wei JT; Udager AM; Chinnaiyan AM; Tomlins SA; Salami SS
    Eur Urol Oncol; 2022 Aug; 5(4):430-439. PubMed ID: 33812851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
    Hendriks RJ; van Oort IM; Schalken JA
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Markers in Prostate Cancer Decision Making.
    Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
    Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenetic markers of early diagnostics of prostate cancer.].
    Peshkov MN
    Klin Lab Diagn; 2018; 63(10):605-609. PubMed ID: 30768880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer biomarkers: an update.
    Romero Otero J; Garcia Gomez B; Campos Juanatey F; Touijer KA
    Urol Oncol; 2014 Apr; 32(3):252-60. PubMed ID: 24495450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
    Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
    Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.
    Tonry CL; Leacy E; Raso C; Finn SP; Armstrong J; Pennington SR
    Diagnostics (Basel); 2016 Jul; 6(3):. PubMed ID: 27438858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume.
    Omri N; Kamil M; Alexander K; Alexander K; Edmond S; Ariel Z; David K; Gilad AE; Azik H
    Prostate; 2020 Dec; 80(16):1444-1449. PubMed ID: 32970856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
    Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
    Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa).
    Stephan C; Rittenhouse H; Hu X; Cammann H; Jung K
    EJIFCC; 2014 Apr; 25(1):55-78. PubMed ID: 27683457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies.
    Lima AR; Bastos Mde L; Carvalho M; Guedes de Pinho P
    Transl Oncol; 2016 Aug; 9(4):357-70. PubMed ID: 27567960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
    Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
    Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PROSTATE CANCER EARLY DETECTION USING PSA - CURRENT TRENDS AND RECENT UPDATES].
    Lavi A; Cohen M
    Harefuah; 2017 Mar; 156(3):185-188. PubMed ID: 28551942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.